Quarterly Transactions Made in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI). The information is specifically focused on institutions that hold shares of BioXcel Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,460,403 | 372,036 | 1,832,439 | 821,150 | 845,578 | 1,666,728 | 165,711 | |
| Q4 2021 | 1,481,649 | 133,919 | 1,615,568 | 213,667 | 283,691 | 497,358 | 1,118,210 | |
| Q1 2022 | 515,655 | 530,713 | 1,046,368 | 1,724,813 | 93,307 | 1,818,120 | -771,752 | |
| Q2 2022 | 1,054,295 | 511,996 | 1,566,291 | 1,405,966 | 421,219 | 1,827,185 | -260,894 | |
| Q3 2022 | 416,198 | 51,245 | 467,443 | 389,188 | 26,632 | 415,820 | 51,623 | |
| Q4 2022 | 140,091 | 2,239,505 | 2,379,596 | 417,638 | 0 | 417,638 | 1,961,958 | |
| Q1 2023 | 3,591,624 | 2,179,693 | 5,771,317 | 1,123,019 | 0 | 1,123,019 | 4,648,298 | |
| Q2 2023 | 1,384,131 | 854,879 | 2,239,010 | 1,260,206 | 0 | 1,260,206 | 978,804 | |
| Q3 2023 | 782,751 | 1,120,059 | 1,902,810 | 7,083,293 | 0 | 7,083,293 | -5,180,483 | |
| Q4 2023 | 646,325 | 584,604 | 1,230,929 | 1,037,777 | 0 | 1,037,777 | 193,152 | |
| Q1 2024 | 450,386 | 705,934 | 1,156,320 | 281,983 | 0 | 281,983 | 874,337 | |
| Q2 2024 | 3,301,055 | 615,139 | 3,916,194 | 2,232,660 | 0 | 2,232,660 | 1,683,534 | |
| Q3 2024 | 334,019 | 167,181 | 501,200 | 1,014,359 | 0 | 1,014,359 | -513,159 | |